Steroid-refractory graft-versus-host disease (SR-GvHD) represents a major complication of
pediatric allogenic hematopoietic stem cell transplantation. Ruxolitinib, a selective JAK 1–2 …

Belumosudil mesylate is a selective Rho‐associated coiled‐coil kinase 2 inhibitor with
immunomodulatory and antifibrosis effects. This multicenter, open‐label, single‐arm study …

Among the potential complications of allogeneic hematopoietic stem cell transplantation
(HSCT), graft-versus-host disease (GVHD) is common and associated with significant …

Background Chronic graft-versus-host disease (cGVHD) is a debilitating late complication of
hematopoietic stem cell transplantation. It is often accompanied by extensive symptom …

Background Preventing the progression of chronic oral graft-versus-host disease (cGVHD) is
essential for maintaining oral health, improving quality of life, minimizing functional …

Systemic steroids are still the first-line approach in acute graft-versus-host disease (aGvHD),
and the backbone of chronic GvHD management. Refractoriness to steroid represent a …

Background Advances in stem cell transplantation have resulted in improved outcomes.
Methods This is a retrospective study aimed to analyze changes in patient profile …

In this issue of Blood, Khandelwal et al report on the results of a randomized, placebo-
controlled phase 2 trial, in which a single dose of oral vitamin A given prior to conditioning …

Cure rates now exceed 90% in many contemporary trials for children with B-cell acute
lymphoblastic leukemia (B-ALL). However, treatment remains suboptimal, and therapy is …

Цель исследования. Оценка социально-экономического бремени хронической реакции
«трансплантат против хозяина»(хрРТПХ) в Российской Федерации. Материалы и …